NAPIFERYN BIOTECH SP ZOO

Their core work

Napiferyn Biotech is a Polish food biotechnology SME that develops industrial processes for producing food-grade proteins from plant sources, with a specific focus on recovering protein from rapeseed oil production waste. Their core technology converts what is typically an industrial byproduct — the press cake or meal left after extracting rapeseed oil — into nutritionally complete, marketable food protein ingredients. They operate at the intersection of food technology and circular bioeconomy, turning an undervalued agricultural waste stream into a commercial protein product. With two consecutive EU SME Instrument grants, they have moved from proof-of-concept to commercial-scale technology development.

What they specialise in

How they've shifted over time

In their first project (FIDOs, 2015–2016), Napiferyn worked on a broad challenge: producing nutritionally complete plant proteins, suggesting early-stage technology exploration across plant raw materials. By their second project (ALSEOS, 2019–2022), the focus had narrowed and sharpened considerably — specifically targeting rapeseed oil production waste as the feedstock, which points to a deliberate strategic decision to own a defensible niche within the plant protein space. The progression from a €50,000 feasibility study to a €2 million commercialization grant over four years indicates the technology was validated and the company pivoted from exploration to scale-up.

Napiferyn is heading toward commercial deployment of a specific industrial biotech process — if ALSEOS delivered, they likely have a market-ready technology for rapeseed protein recovery and may be seeking licensing partners, manufacturing scale-up, or food industry customers rather than further R&D funding.

How they like to work

Napiferyn operates exclusively through the SME Instrument funding scheme, which is designed for individual companies developing their own proprietary technology — both of their projects were solo grants with no consortium partners. This means they are not experienced in large multi-partner consortia and likely prefer to maintain full control over their IP and development process. A potential collaborator should expect to engage them as a technology provider or licensing partner rather than as a co-developer sharing a research agenda.

No external consortium partners are recorded across either project, which is expected for SME Instrument grants that fund single companies. Their network in the EU research sense is essentially zero — but their industry connections are likely within the Polish and Central European oilseed processing and food ingredients sectors.

What sets them apart

Napiferyn occupies a very specific niche: protein recovery from rapeseed oil production waste, which is highly relevant to Poland — one of the largest rapeseed producers in the EU. Few food biotech SMEs have successfully secured both a Phase 1 and Phase 2 SME Instrument grant in the same technology area, which signals that independent EU evaluators twice validated both the technology and the commercial case. For a consortium builder or industry partner in the oilseed or alternative protein space, they offer proprietary process know-how that is unlikely to be replicated by a university lab or large food company.

Highlights from their portfolio

• ALSEOS
  A €2 million SME Instrument Phase 2 grant — the hardest category to win — specifically for commercializing a technology that converts rapeseed oil waste into food protein, making it by far their most significant and commercially consequential project.
• FIDOs
  The Phase 1 feasibility study that preceded ALSEOS, notable because its success directly unlocked the Phase 2 grant, confirming the company's ability to execute a structured technology development roadmap.